Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04574635 · ClinicalTrials.gov registry record

Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer

A clinical trial of Cervical Adenosquamous Carcinoma and Recurrent Cervical Carcinoma, sponsored by Mayo Clinic.

Active
Registry status
18
Enrollment target
2
Study locations

NCT04574635 is a study of Cervical Adenosquamous Carcinoma and Recurrent Cervical Carcinoma that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 18 participants, below the 113-participant average among 13 other Cervical Adenosquamous Carcinoma trials with a reported enrollment target (84% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04574635, a study of Cervical Adenosquamous Carcinoma and Recurrent Cervical Carcinoma, is active but no longer recruiting, sponsored by Mayo Clinic.

ACTIVE NOT RECRUITING
Registry status
18 participants
Enrollment target
2
Study locations

Study Summary

This study collects blood samples to determine if the DNA of HPV that causes cervical cancer can be detected in patients with cervical cancer that is new (primary), has come back (recurrent), or has spread to other places in the body (metastatic) and are undergoing treatment with surgery, radiotherapy, chemotherapy, and/or immunotherapy. Researchers may use this information to predict response (good or bad) of the cervical cancer to treatment and detect recurrent cancer sooner.

Conditions Studied

Cervical Adenosquamous Carcinoma Recurrent Cervical Carcinoma Cervical Squamous Cell Carcinoma, Not Otherwise Specified Metastatic Cervical Carcinoma Stage IB Cervical Cancer FIGO 2018 Infiltrating Cervical Carcinoma Stage I Cervical Cancer FIGO 2018 Stage IA Cervical Cancer FIGO 2018 Stage IA1 Cervical Cancer FIGO 2018 Stage IA2 Cervical Cancer FIGO 2018

Interventions

  • PROCEDURE Biospecimen Collection

Study Locations (2)

Minnesota

  • University of Minnesota - Minneapolis
  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2020-11-17
Est. Completion 2027-11-30

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04574635

The ClinicalTrials.gov registry entry for NCT04574635 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 113-participant average among 13 other Cervical Adenosquamous Carcinoma trials with a reported enrollment target (84% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Cervical Adenosquamous Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Biospecimen Collection is the first listed.

NCT04574635 reports 2 study locations spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT04574635 about?

NCT04574635 is a clinical study titled "Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer". This study collects blood samples to determine if the DNA of HPV that causes cervical cancer can be detected in patients with cervical cancer that is new (primary), has come back (recurrent), or has spread to other places in the body (metastatic) and are undergoing treatment with surgery, radiothera...

What is the current status of trial NCT04574635?

This trial is currently active not recruiting. The enrollment target is 18 participants. The study started on 2020-11-17. Estimated completion is 2027-11-30.

What conditions does trial NCT04574635 study?

This clinical trial studies the following conditions: Cervical Adenosquamous Carcinoma, Recurrent Cervical Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified, Metastatic Cervical Carcinoma, Stage IB Cervical Cancer FIGO 2018.

What interventions are being tested in trial NCT04574635?

The interventions under investigation include: Biospecimen Collection (PROCEDURE).

Who is sponsoring clinical trial NCT04574635?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04574635 being conducted?

This trial has 2 study locations across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cervical Adenosquamous Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cervical Adenosquamous Carcinoma

All registered trials for this condition

Recurrent Cervical Carcinoma

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.